These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 16680555)

  • 1. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria.
    Krzyzanowska K; Mittermayer F; Shnawa N; Hofer M; Schnabler J; Etmüller Y; Kapiotis S; Wolzt M; Schernthaner G
    Diabet Med; 2007 Jan; 24(1):81-6. PubMed ID: 17227328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G; Fermo I; Aman CS; Ferraroni M; Secchi A; Fiorina P; Paroni R
    Free Radic Biol Med; 2009 Aug; 47(3):307-11. PubMed ID: 19446631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
    Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
    Mittermayer F; Pleiner J; Krzyzanowska K; Wiesinger GF; Francesconi M; Wolzt M
    Wien Klin Wochenschr; 2005 Dec; 117(23-24):816-20. PubMed ID: 16437318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
    Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
    Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
    Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
    Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
    Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
    J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects.
    Paroni R; Fermo I; Fiorina P; Cighetti G
    Amino Acids; 2005 Jun; 28(4):389-94. PubMed ID: 15827687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.
    Fleck C; Schweitzer F; Karge E; Busch M; Stein G
    Clin Chim Acta; 2003 Oct; 336(1-2):1-12. PubMed ID: 14500028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G; Umbrello M; Albicini M; Spanu P; Bellani G; Polli F; Pavlovic R; Cugno M; Fermo I; Paroni R
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.
    Esposito C; Grosjean F; Torreggiani M; Maggi N; Esposito V; Migotto C; Mangione F; Tinelli C; Dal Canton A
    Transplant Proc; 2009 Jun; 41(5):1570-3. PubMed ID: 19545681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism.
    Haider DG; Bucek RA; Reiter M; Minar E; Hron G; Kyrle PA; Mittermayer F; Wolzt M
    Transl Res; 2006 Jul; 148(1):26-9. PubMed ID: 16887495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.